Abstract
Objective To report a case of immune mediated hemolysis occurring after oxaliplatin infusion in a patient with rectal cancer. Case summary We report a 69 year old male patient who presented with acute onset anemia after infusion of oxaliplatin as chemotherapy. A positive direct Coombs test and good response to steroids treatment underlined the diagnosis of immune related hemolytic anemia. The patient was switched to irinotecan-based chemotherapy regimen for further treatment. Discussion To our knowledge, there has been less than 10 cases of hemolysis occurring after oxaliplatin treatment in the medical literature. In all cases, immune mediated hemolysis has been proven with a positive coombs test. As oxaliplatin based chemotherapy regimen has become a standardized first line treatment for metastatic colorectal adenocarcinoma, this phenomenon warrants a higher level of physician awareness. Conclusions Oxaliplatin related hemolytic anemia is a rare reported phenomenon. Patient under oxaliplatin treatment presenting with sudden hemoglobin decrease should prompt further investigation of hemolysis.
This is a preview of subscription content, log in via an institution to check access.
References
Gundling F, Tiller M, Fuchs M, Schepp W. Immune-mediated hemolytic anemia under oxaliplatin. Z Gastroenterol. 2008;46(7):695–9. doi:10.1055/s-2007-963721.
Santodirocco M, Lombardi V, Fesce C, Palumbo G, Capalbo S, Landriscina M. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report. Acta Oncol. 2008;47(8):1602–4. doi:10.1080/02841860801978913.
Cobo F, De Celis G, Pereira A, Latorre X, Pujadas J, Albiol S. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Anticancer Drugs. 2007;18(8):973–6.
Noronha V, Burtness B, Murren J, Duffy TP. Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature. Clin Colorectal Cancer. 2005;5(4):283–6. doi:10.3816/CCC.2005.n.041.
Koutras AK, Makatsoris T, Paliogianni F, Kopsida G, Onyenadum A, Gogos CA, et al. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology. 2004;67(2):179–82. doi:10.1159/000081006.
Chen VM, Thrift KM, Morel-Kopp MC, Jackson D, Ward CM, Flower RL. An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Transfusion. 2004;44(6):838–43. doi:10.1111/j.1537-2995.2004.03111.x.
Hofheinz RD, Nguyen XD, Buchheidt D, Kerowgan M, Hehlmann R, Hochhaus A. Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient. Cancer Chemother Pharmacol. 2004;53(3):276–7. doi:10.1007/s00280-003-0731-8.
Sørbye H, Bruserud Y, Dahl O. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol. 2001;40(7):882–3. doi:10.1080/02841860152703553.
Dahabreh I, Tsoutsos G, Tseligas D, Janinis D. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report. BMC Clin Pharmacol. 2006;6:5.
Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009;8(1):73–9. doi:10.1517/14740330802577351.
Funding
None
Conflicts of interest statement
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, JI., Wang, WS. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review. Pharm World Sci 31, 538–541 (2009). https://doi.org/10.1007/s11096-009-9313-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-009-9313-0